Ionis Pharmaceuticals CEO Brett Monia's 2020 pay jumps 68% to $11M
Ionis Pharmaceuticals reports 2020 executive compensation
By ExecPay News
Published: April 23, 2021
Ionis Pharmaceuticals reported fiscal year 2020 executive compensation information on April 23, 2021.
In 2020, five executives at Ionis Pharmaceuticals received on average a compensation package of $6.6M, a 21% increase compared to previous year.
Average pay of disclosed executives at Ionis Pharmaceuticals
Brett Monia, Chief Executive Officer, received $11M in total, which increased by 68% compared to 2019. 47% of Monia's compensation, or $5.2M, was in stock awards. Monia also received $602K in bonus, $4.5M in option awards, $700K in salary, as well as $41K in other compensation.
For fiscal year 2020, the median employee pay was $352,641 at Ionis Pharmaceuticals. Therefore, the ratio of Brett Monia's pay to the median employee pay was 31 to one.
Stanley T. Crooke, Chairman, received a compensation package of $9.5M, which decreased by 1% compared to previous year. 45% of the compensation package, or $4.3M, was in option awards.
Elizabeth L. Hougen, Chief Financial Officer, earned $4.3M in 2020, a 25% increase compared to previous year.
Richard S. Geary, Executive Vice President, Chief Development Officer, received $4M in 2020, which increases by 3% compared to 2019.
Patrick R. O'Neil, General Counsel, earned $4M in 2020, a 14% increase compared to previous year.
Related executives
Brett Monia
Ionis Pharmaceuticals
Chief Executive Officer
Elizabeth Hougen
Ionis Pharmaceuticals
Chief Financial Officer
Stanley Crooke
Ionis Pharmaceuticals
Chairman
Richard Geary
Ionis Pharmaceuticals
Executive Vice President, Chief Development Officer
Patrick O'Neil
Ionis Pharmaceuticals
General Counsel
You may also like
Source: SEC filing on April 23, 2021.